BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 30152569)

  • 21. Acute generalized exanthematous pustulosis induced by generic hydroxychloroquine.
    Wang G; Zhuo N; Li J
    J Cosmet Dermatol; 2022 Aug; 21(8):3608-3610. PubMed ID: 34757679
    [No Abstract]   [Full Text] [Related]  

  • 22. Acute generalized exanthematous pustulosis after COVID-19 treatment with hydroxychloroquine.
    Litaiem N; Hajlaoui K; Karray M; Slouma M; Zeglaoui F
    Dermatol Ther; 2020 Jul; 33(4):e13565. PubMed ID: 32401410
    [No Abstract]   [Full Text] [Related]  

  • 23. Generalized pustular figurate erythema: A newly delineated severe cutaneous drug reaction linked with hydroxychloroquine.
    Schwartz RA; Janniger CK
    Dermatol Ther; 2020 May; 33(3):e13380. PubMed ID: 32253799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acute generalized exanthematic pustulosis induced by hydroxychloroquine: case report].
    Djennane M; Tablit I; Billhot M; Banal F
    Rev Med Interne; 2010 Mar; 31(3):e7-8. PubMed ID: 20089332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute generalized exanthematous pustulosis due to ceftriaxone: Report of a pediatric case with recurrence after positive patch test.
    Salman A; Yucelten D; Akin Cakici O; Kepenekli Kadayifci E
    Pediatr Dermatol; 2019 Jul; 36(4):514-516. PubMed ID: 31050838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Initiation of hydroxychloroquine therapy during pregnancy can cause adverse effects and alter pregnancy outcomes: A case of acute generalised exanthematous pustulosis induced by hydroxychloroquine in a patient with systemic lupus erythematosus.
    Tsurane K; Kaneko K; Yoshida K; Tanaka R; Sago H; Murashima A
    Mod Rheumatol Case Rep; 2023 Jun; 7(2):373-377. PubMed ID: 36420890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute generalized exanthematous pustulosis with erythema multiforme-like lesions induced by Hydroxychloroquine in a woman with coronavirus disease 2019 (COVID-19).
    Robustelli Test E; Vezzoli P; Carugno A; Raponi F; Gianatti A; Rongioletti F; Sena P
    J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):e457-e459. PubMed ID: 32386448
    [No Abstract]   [Full Text] [Related]  

  • 28. Rapid clearing of acute generalized exanthematous pustulosis after administration of ciclosporin.
    Di Lernia V; Grenzi L; Guareschi E; Ricci C
    Clin Exp Dermatol; 2009 Dec; 34(8):e757-9. PubMed ID: 19663832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First case report of acute generalized exanthematous pustulosis (AGEP) caused by mifepristone.
    Zhang L; Qian M; Hong L; Wu Q
    Contact Dermatitis; 2020 Mar; 82(3):177-179. PubMed ID: 31626328
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hydroxychloroquine-puvatherapy photoinduced acute generalized exanthematous pustulosis].
    Bonnetblanc JM; Combeau A; Dang PM
    Ann Dermatol Venereol; 1995; 122(9):604-5. PubMed ID: 8745685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute generalized exanthematous pustulosis following treatment with favipiravir in a patient with COVID-19 without hydroxychloroquine use: Report of the first case.
    Atak MF; Farabi B; Akbayrak A; Kalelioğlu MB; Rao BK
    J Cosmet Dermatol; 2021 Aug; 20(8):2387-2389. PubMed ID: 34139069
    [No Abstract]   [Full Text] [Related]  

  • 32. Successful Treatment of Hydroxychloroquine-Induced Recalcitrant Acute Generalized Exanthematous Pustulosis with Cyclosporine: Case Report and Literature Review.
    Yalçın B; Çakmak S; Yıldırım B
    Ann Dermatol; 2015 Aug; 27(4):431-4. PubMed ID: 26273160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Acute cutaneous pustular eruption due to hydroxychloroquine].
    Pastushenko I; Gracia-Cazaña T; Morales-Moya AL; Grasa MP
    Med Clin (Barc); 2014 Oct; 143(7):e13. PubMed ID: 24908623
    [No Abstract]   [Full Text] [Related]  

  • 34. Acute generalized exanthematous pustulosis associated with 2 common medications: hydroxyzine and benzocaine.
    O'Toole A; Lacroix J; Pratt M; Beecker J
    J Am Acad Dermatol; 2014 Oct; 71(4):e147-9. PubMed ID: 25219740
    [No Abstract]   [Full Text] [Related]  

  • 35. Two cases of annular acute generalized exanthematous pustulosis induced by terbinafine.
    Olivier S; De Montjoye L; Tromme I; Baeck M
    Eur J Dermatol; 2018 Apr; 28(2):236-238. PubMed ID: 29336314
    [No Abstract]   [Full Text] [Related]  

  • 36. Acute generalized exanthematous pustulosis associated with ranolazine.
    Grelck K; Stewart N; Rosen L; Sukal S
    Cutis; 2015 Oct; 96(4):E18-21. PubMed ID: 26682297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute generalized exanthematous pustulosis induced by isotretinoin.
    da Cunha Filho RR; de Almeida HL; Lorencette NA; Fillus Netto J
    Int J Dermatol; 2010 Sep; 49(9):1077-9. PubMed ID: 20883276
    [No Abstract]   [Full Text] [Related]  

  • 38. Acute generalized exanthematous pustulosis induced by celecoxib.
    Lee SK; Lee DY; Kim DJ; Kim MS; Lee UH; Hahm JH
    J Cutan Pathol; 2016 Jan; 43(1):80-1. PubMed ID: 26488335
    [No Abstract]   [Full Text] [Related]  

  • 39. Hydroxychloroquine-induced acute generalized exanthematous pustulosis in an orofacial granulomatosis patient with homozygous IL36RN mutation.
    Yan C; Shang Q; Geng S
    Dermatol Ther; 2022 Aug; 35(8):e15587. PubMed ID: 35575468
    [No Abstract]   [Full Text] [Related]  

  • 40. Acute generalized exanthematous pustulosis: clinical characteristics, etiologic associations, treatments, and outcomes in a series of 28 patients at Mayo Clinic, 1996-2013.
    Alniemi DT; Wetter DA; Bridges AG; El-Azhary RA; Davis MD; Camilleri MJ; McEvoy MT
    Int J Dermatol; 2017 Apr; 56(4):405-414. PubMed ID: 28084022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.